Please use this identifier to cite or link to this item:
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles
Peer Review Status: Refereed
Title: Supporting Advanced Dementia in people with Down syndrome and other intellectual disabilities: Consensus Statement of the International Summit on Intellectual Disability and Dementia
Author(s): McCarron, Mary
McCallion, Philip
Coppus, Antonia
Fortea, Juan
Stemp, Sandy
Janicki, Matthew
Watchman, Karen
Contact Email:
Keywords: assessment
Issue Date: 20-May-2018
Citation: McCarron M, McCallion P, Coppus A, Fortea J, Stemp S, Janicki M & Watchman K (2018) Supporting Advanced Dementia in people with Down syndrome and other intellectual disabilities: Consensus Statement of the International Summit on Intellectual Disability and Dementia. Journal of Intellectual Disability Research.
Abstract: The International Summit on Intellectual Disability and Dementia (Glasgow, Scotland; October 2016) noted that advanced dementia can be categorised as that stage of dementia progression characterised by significant losses in cognitive and physical function, including a high probability of further deterioration and leading to death. The questions before the Summit were whether there were similarities and differences in expressions of advanced dementia between adults with intellectual disability and adults in the general population.  The Summit noted challenges in the staging of advanced dementia in people with ID with the criteria in measures designed to stage dementia in the general population heavily weighted on notable impairment in activities of daily living. For many people with an intellectual disability (ID) there is already dependence in these domains generally related to the individuals preexisting level of intellectual impairment, i.e., totally unrelated to dementia. Hence, the summit agreed that as was true in achieving diagnosis, it is also imperative in determining advanced dementia that change is measured from the person’s prior functioning in combination with clinical impressions of continuing and marked decline and of increasing co-morbidity, including particular attention to late onset epilepsy in people with Down syndrome. It was further noted that quality care planning must recognise the greater likelihood of physical symptoms, comorbidities, immobility and neuropathological deterioration.  The Summit recommended an investment in research to more clearly identify measures of person-specific additional decline for ascertaining advanced dementia, inform practice guidelines to aid clinicians and service providers, and to identify specific markers that signal such additional decline and progression into advanced dementia among people with various levels of pre-existing intellectual impairment.
DOI Link: 10.1111/jir.12500
Rights: This item has been embargoed for a period. During the embargo please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.
Notes: Output Status: Forthcoming/Available Online

Files in This Item:
File Description SizeFormat 
Advanced dementia paper JIDR 2018.pdfFulltext - Accepted Version351.86 kBAdobe PDFView/Open

This item is protected by original copyright

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact providing details and we will remove the Work from public display in STORRE and investigate your claim.